The current state of randomized clinical trial evidence for prostate brachytherapy.

The current state of randomized clinical trial evidence for prostate brachytherapy.
Urol Oncol. 2019 May 03;:
Authors: Dess RT, Soni PD, Jackson WC, Berlin A, Cox BW, Jolly S, Efstathiou JA, Feng FY, Kishan AU, Stish BJ, Pisansky TM, Spratt DE
Abstract
Interstitial brachytherapy is one of several curative therapeutic options for the treatment of localized prostate cancer. In this review, we summarize all available randomized data to support the optimal use of prostate brachytherapy. Evidence from completed randomized controlled trials is the focus of this review with a presentation also of important ongoing trials. Gaps in knowledge are identified where future investigation may be fruitful with intent to inspire well-designed prospective studies with standardized treatment that focuses on improving oncological outcomes, reducing morbidity, or maintaining quality of life.
PMID: 31060795 [PubMed - as supplied by publisher]

Source: Urologic Oncology - May 2, 2019 Category: Urology & Nephrology Authors: Dess RT, Soni PD, Jackson WC, Berlin A, Cox BW, Jolly S, Efstathiou JA, Feng FY, Kishan AU, Stish BJ, Pisansky TM, Spratt DE Tags: Urol Oncol Source Type: research